Zanolimumab is a fully human monoclonal antibody that specifically targets CD4, a critical molecule in the T-cell receptor (TCR) signaling pathway. By binding to CD4, Zanolimumab effectively inhibits TCR signal transduction, impacting T-cell activation and function. This antibody is utilized in research focused on various immune-related conditions and cancers, including rheumatoid arthritis, psoriasis, melanoma, and both cutaneous and peripheral T-cell lymphoma. Its precise targeting makes it a valuable tool for studies aimed at understanding T-cell behavior and for developing therapeutic strategies against diseases mediated by T-cells.
Zanolimumab is a fully human monoclonal antibody that specifically targets CD4, a critical molecule in the T-cell receptor (TCR) signaling pathway. By binding to CD4, Zanolimumab effectively inhibits TCR signal transduction, impacting T-cell activation and function. This antibody is utilized in research focused on various immune-related conditions and cancers, including rheumatoid arthritis, psoriasis, melanoma, and both cutaneous and peripheral T-cell lymphoma. Its precise targeting makes it a valuable tool for studies aimed at understanding T-cell behavior and for developing therapeutic strategies against diseases mediated by T-cells.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula:
